AI in life sciences

Digital

pharmaphorum podcast Episode 176a - Andrew Stelzer, Unlearn.AI

AI in drug development: The real hurdle is implementation

Web editor Nicole Raleigh speaks with Andrew Stelzer, head of business development at Unlearn.AI, about effectively implementing AI.

R&D

Reinventing R&D in the age of AI - How intelligent technolog...

Life-changing interventions that have previously been pipedreams are now within reach for the biopharma industry, made possible through an increasingly sophisticated understanding of human

Sales & Marketing

The AI edge: Redefining commercial excellence in 2025

Biopharma companies are increasingly turning to artificial intelligence (AI) to enhance customer-focused commercial strategies, driving more tailored engagement and improved operational eff

Digital

Smart search to seamless care: How AI will transform experie...

The world changed when GenAI emerged two years ago with the introduction of ChatGPT.

Digital

In conversation at Veeva Summit: Jonathan Crowther, Pfizer

At the Veeva Commercial Summit in Madrid at the end of 2024, pharmaphorum web editor Nicole Raleigh sat down with Pfizer’s head of predictive analytics, Jonathan Crowther, to discuss the ro

Digital

Life Sciences Industry Report 2025 pt3 cover

Life Sciences Industry Report – Articial Intelligence

Artificial intelligence (AI) has long promised to transform the life sciences, but today, we stand at a critical juncture where this potential is rapidly becoming a reality.

AI in drug development: The real hurdle is implementation

Reinventing R&D in the age of AI - How intelligent technolog...

The AI edge: Redefining commercial excellence in 2025

Smart search to seamless care: How AI will transform experie...

In conversation at Veeva Summit: Jonathan Crowther, Pfizer

Life Sciences Industry Report – Articial Intelligence

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

AI in life sciences

Editor's Picks